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ABSTRACT A quantitative real-time assay of cell-free endosomal vesicle fusion was developed and applied to study fusion
mechanisms in endosomes from baby hamster kidney (BHK-21) cells. The assay is based on an irreversible -1 0-fold increase
in BODIPY-avidin fluorescence on binding of biotinylated conjugates. BODIPY-avidin and biotin-dextran were internalized for
10 min at 370C into separate populations of BHK-21 cells, and endosome fractions were prepared. Postnuclear supernatant
fractions underwent ATP- and temperature-dependent fusion, as measured in a sensitive custom-built microfluorimeter by
the continuous increase in BODIPY-avidin fluorescence. Fusion processes of efficiency >2.5% could be detected with
200-ms time resolution in sample volumes of 50 ,uL containing endosomes derived from -4 x 104 cells. The fusion time
course consisted of a distinct lag phase (up to 10 min) in which little fusion occurred, followed by an approximately
exponential rise (t1l2 10-30 min; fusion efficiency -15%). The lag phase was reduced by preincubation of separate endosome
fractions with ATP at 370C and by coincubation of endosomes at 220C before the assay, suggesting a rate-limiting step
involving binding of a soluble protein to the endosome membrane. Endosome fusion was strongly inhibited by GTPyS,
N-ethylmaleimide, and AIF4-. Endosome fusion was not affected by phorbol myristate acetate but was significantly inhibited
by cAMP and bovine brain calmodulin. The results establish a sensitive real-time fluorescence assay to quantify the kinetics
and extent of endosome fusion in a cell-free system and demonstrate regulation of early endosome fusion by cytosolic
second messengers.
INTRODUCTION
Fusion between endocytic compartments underlies the pro-
cesses of receptor-mediated and fluid-phase endocytosis in
mammalian cells (Kornfeld and Mellman, 1989; Gruenberg
and Howell, 1989; Braell, 1992; Goda and Pfeffer, 1989,
1991; Gruenberg et al., 1989; Aniento et al., 1993; Emans et
al., 1993, 1995). Clathrin-coated vesicles derived from the
cell plasma membrane fuse with a peripheral tubulovesicu-
lar compartment, defined as the early endosome, delivering
receptor-bound ligands and fluid-phase markers from the
extracellular medium. Most internalized markers subse-
quently appear in perinuclear late endosomes after passage
through an intermediate endosomal carrier vesicle. Several
steps of the endocytic pathway have been reconstituted in
cell-free assays (for review: Goda and Pfeffer, 1989). Early
endosomes undergo homotypic fusion in vitro (Gruenberg
et al., 1989; Braell, 1987; Diaz et al., 1988) but do not fuse
with late endosomes or endosomal carrier vesicles (Gruen-
berg et al., 1989; Aniento et al., 1993; Emans et al., 1993;
Goda and Pfeffer, 1988; Woodman et al., 1992; Braell,
1987; Davey et al., 1985; Clague et al., 1994). Fusion of
endosomal carrier vesicles to late endosomes has been
shown to require intact microtubules and cytoplasmic dy-
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nein (Aniento et al., 1993). Early endosome fusion is reg-
ulated by rabS, a member of the sec4/yptl/rab family of
small ras-like monomeric GTPases (Gorvel et al., 1991) and
by protein phosphorylation (Woodman et al., 1992) and to
utilize factors that are also involved in intra-Golgi transport
(Diaz et al., 1989a). Many of these factors may constitute
regulatory components of the ubiquitous membrane fusion/
recognition apparatus proposed in the SNARE hypothesis
(Sollner et al., 1993).
Classical endosome fusion assays have exploited high
affinity avidin-biotin or antibody-antigen interactions to
measure the extent of fusion between vesicle preparations
labeled independently by internalization (Colombo et al.,
1992a; Braell, 1987; Gruenberg and Gorvel, 1992). Various
detection methods have been used to quantify the amount of
a complex formed from fusion-dependent intermixing of
endosomal contents. For example, avidin or biotinylated
horseradish peroxidase is internalized into cells. Endosomes
are prepared separately and mixed under in vitro conditions
similar to those used for cell-free reconstitution of intra-
Golgi transport (Braell, 1987; Gruenberg and Gorvel, 1992;
Balch et al., 1984; Braell et al., 1984). After specified
incubation time(s) at 37°C, the endosome mixture is solu-
bilized, immunoprecipitated with an antiavidin antibody,
and the coimmunoprecipitated peroxidase activity taken as a
measure of the intermixing of endosomal contents (Gruen-
berg et al., 1989; Gruenberg and Gorvel, 1992).
Cell-free assays provide a general method to identify the
factors that are involved in the regulation of endosome
fusion (Goda and Pfeffer, 1989; Gorvel et al., 1991). In
addition, the analysis of fusion kinetics permits the identi-
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fication of rate-limiting steps in the fusion process and the
site of action of regulatory factors. A limitation of available
assays is that data can be obtained only at single time points
because the fusion reaction must be stopped and the extent
of intermixing of endosome contents measured. Because of
technical concerns in the accurate measurement of immu-
noprecipitated substrates at multiple time points, the assays
are not easily applicable to quantify the detailed kinetics of
fusion and to define the mechanisms by which regulatory
factors modulate fusion.
We report here a sensitive fluorescence assay that mon-
itors endosome fusion quantitatively as it proceeds in real
time. Compared with conventional biochemical assays re-
ferred to above, the fluorescence assay permits the accurate
analysis of detailed fusion kinetics in very small samples.
Our approach was based on the finding that the fluorescence
of BODIPY-avidin (B-av) increases strongly (by - 10 fold)
on binding of a biotinylated substrate and that this avidin-
biotin interaction could be exploited to follow endosome
fusion in living cells by ratio imaging of individually la-
beled endosomes (Emans et al., 1995). The B-av/biotin
system satisfies the major requirements of a cell-free endo-
some fusion assay: the increase in BODIPY fluorescence
signal on biotin binding is easily measured, very rapid (t,/2
< 25 ms), pH insensitive, and essentially irreversible (dis-
sociation tl2 > 24 h). In addition, the validity of various
avidin and biotin conjugates as markers of fluid-phase or
receptor-mediated endocytosis has already been established
in cell-free endosome assays and in our recent study of
endosome fusion in living cells. The experiments reported
here utilized established in vitro fusion conditions in which
endosome fractions were prepared from cells after internal-
ization of B-av or biotin-dextran. After mixing of the la-
beled vesicles, endosome fusion was detected from the time
course of increase in BODIPY fluorescence. A sensitive
microfluorimeter was constructed to optimize the fluores-
cence signal from a small sample volume and to perform
multiple fusion assays in parallel. The cell-free assay was
first validated by use of known modulators of endosome
fusion and then applied to characterize an interesting lag
phase in fusion kinetics and the influence of cytosol second
messengers.
MATERIALS AND METHODS
Materials
BODIPY-avidin (B-av), amino dextran (MW 10,000), and biotinamido
caproate-N-hydroxysuccinimidyl ester (biotin-X-NHS) were purchased
from Molecular Probes (Eugene, OR). Creatine kinase, ATP, GTP-yS, and
creatine phosphate were purchased from Boehringer Mannheim (Mann-
heim, Germany). Purified bovine brain calmodulin and the sodium salts of
cAMP, phorbol 12-myristate 13-acetate, H89, Go6976, and KN-62 were
from Calbiochem (San Diego, CA). All other chemicals were purchased
from Sigma (St. Louis, MO). Tissue culture reagents were obtained from
the University of California, San Francisco, tissue culture facility. Trans-
parent plastic vials were from Continental Labsystems-Denley (Needem
Heights, MA). Amino dextran was biotinylated by reaction at 10 mg/mL in
0.1 M NaHCO3 for 2 h at 20°C with a fivefold excess of biotin-X-NHS.
Products were dialyzed against 10 mM Na2CO3 for 36-72 h and
lyophilized.
Cell culture
Baby hamster kidney cells (BHK-21 [C-13] ATCC CCL 10, passages 1-15
after cloning) were grown at 37°C in 95% air/5% CO2 in DME-21 medium
supplemented with 10% heat-inactivated (20 min at 56°C) fetal bovine
serum and 1% penicillin-streptomycin. Cells were plated at a density of
105/mL on 10-cm-diameter tissue culture-treated plastic dishes (Falcon
Labware) and used when confluent.
Endosome labeling procedures
Cells were released into suspension by a 20-30-min incubation in Ca2+-
and Mg2+-free phosphate buffered saline containing 10 mM D-glucose, 10
mM Hepes-NaOH (pH 7.4), and 4 mM EGTA at 37°C in a 95% air/5%
CO2 atmosphere. The suspended cells were washed twice with Hepes
buffered saline (20mM Hepes-NaOH pH 7.4, 5 mM KCI, 5 mM D-glucose,
and 0.15 M NaCl) by centrifugation (800 X g) for 10 min at 40C. Cells
were labeled in suspension by a 10-min incubation at 37°C with 0.5 mg/nmL
B-av in 50 mM Na2CO3, 5 mM KCI, 10 mM D-glucose, 12 mM Hepes-
NaOH (pH 7.4), 75 mM NaCl, or 4 mg/mL biotin-dextran (in phenol
red-free DME-H21 containing 10mM Hepes-NaOH and 5 mM D-glucose).
Labeled cells were then washed three times with Hepes buffered saline by
centrifugation (800 X g, 5 min, 4°C) and then pelleted in homogenization
buffer (250 mM D-glucose, 3 mM imidazole pH 7.4, 2 ug/mL aprotinin, 2
,uM pepstatin) at 3000 X g for 15 min at 4°C.
Preparation of endosome fractions and cytosol
Cells were homogenized by passage through a 22-gauge steel needle until
cell breakage was estimated to be 80% by phase contrast microscopy
(Emans et al., 1993; Gruenberg and Gorvel, 1992). Nuclei and cell debris
were removed by centrifugation (3000 X g) for 10 min at 4°C. The
resultant postnuclear supernatants (8-13 mg protein/mL) were pooled and
snap frozen in liquid nitrogen before storage at -80°C. Rat liver cytosol
was prepared as described (Bomsel and Mostov, 1993), snap frozen, and
stored at -80°C. Protein concentration was determined by the Bradford
microassay (Bradford, 1976).
Cell-free fusion reactions
Postnuclear supernatants or cytosol fractions were rapid thawed at 40°C for
30 s and placed on ice. Solution concentrations were raised to 50 mM
KOAc, 400 ,ug/mL unlabeled avidin, 12.5 mM Hepes-NaOH (pH 7.4), 1
mM DTT, and 2.5 mM MgOAc as described (Gruenberg and Gorvel, 1992)
and incubated for 1 min at 4°C. Complete assay mixtures (generally 25 AL
[acceptor] avidin-labeled fraction: 25 ,uL [donor] biotin-labeled fraction)
were deposited in plastic vials precoated with rat liver cytosol (2 mg
protein/mL in homogenization buffer, 12 h at 4°C). An ATP-regenerating
mixture (Colombo et al., 1992a) (freshly dissolved 6400 units/mL creatine
kinase in 10 mM Na2HPO4) was mixed with an equal quantity of homog-
enization buffer and then mixed 1:1 with 100 mM ATP (pH 7.2-7.6,
adjusted with NaOH) and 800 mM creatine phosphate. 1.5 ,uL of the ATP
regenerating mixture was added to the assay mixture in the vials (final 1
mM ATP, 8 mM creatine phosphate, 32 units/mL creatine kinase). In some
experiments, ATP was depleted by addition to the assay mixture of 1.5 ,uL
of 1500 units/mL yeast hexokinase lyophilizate in 250 mM D-glucose (30
units/mL final) (Balch et al., 1984). Assays were generally begun by rapid
warming of the mixture to 37°C (<2 min) in a custom-designed micro-
scope stage (see below) and continued for >1 h. At the completion of the
assay, biotin methyl ester (2 p.L of 50-mM stock in DMSO) was added to
the reaction mixture in situ to give maximum B-av fluorescence for
determination of the absolute fusion efficiencies (see below).
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Fluorescence instrumentation
A computer-controlled multisample microfluorimeter was constructed on
the chassis of an upright Nikon Labophot (Melville, NY) microscope. A
14.0 cm X 17.5 cm X 3.0 cm aluminum block was machined to give a
centered insert, which accommodated six plastic vials. A 36-inch-long,
three-sixteenth-inch-diameter heating wire (Cole Palmer, Niles, IL) and a
PVC-coated, type J thermocouple were embedded in the block for contin-
uous temperature control. Temperature control was accomplished with a
closed-loop feedback controller (Yokogawa model 89700, Cole Palmer)
coupled to the thermocouple and the heating wire. Temperature was
maintained constant to within 0.1 °C. The block was mounted on the
microscope stage. One-dimensional stage translation was accomplished by
mechanical coupling of the stage translator to a five-phase microstepper
motor (UPS502-535MA, Nyden Corp., Santa Clara, CA) driven by a MAC
300 (Nyden) motor controller. Stage x-position was computer controlled
with a precision of better than 0.05 mm and a maximum velocity of 50
mm/s.
The light source was a 100-W tungsten-halogen lamp powered by a
stabilized power supply (model 68735, Oriel, Stratford, CT). The lamp was
housed and light collimated by a Nikon focusing accessory designed as a
light source for epi-illumination. Excitation light was filtered by two 485
± 22 nm six-cavity interference filters (blocked from UV to IR) in series
(Omega Optical, Brattleboro, VT). The monochromatic light was reflected
by a 45° concave mirror and focused onto the sample by a plano-convex
glass lens (focal length 5 cm) fixed beneath the stage. Emitted fluorescence
was collected by a custom-built objective (N.A. 0.16, working distance 5
cm) and filtered by three 535 ± 35 nm interference filters (Omega Optical)
in series mounted directly above the objective. The signal was detected by
an 1 1-dynode photomultiplier (R928S, Hamamatsu, Middlesex, NJ) pow-
ered by a dc high-voltage supply (Ealing model 110, Natick, MA). The
signal was amplified and digitized at 30 Hz by a 12-bit analog-to-digital
converter (ADALAB, Interactive Microware, State College, PA). Motor
movement and signal acquisition were controlled by a 486 PC. Software
was written in Quick Basic 4.5 to move the stage from well to well with
specified dwell times (generally 1 s, average of 25 points at 40 ms/point,
24 wells measured/min) and to record averaged photomultiplier signals
together with corresponding times. The microscope optics were encased in
a light-tight box and mounted upon a self-leveling floating optical table
(Newport NS 1000, Irvine, CA). The light source and the detection elec-
tronics were stable over 1 h to better than 0.2% as judged from the signal
from fluorophore standards.
Data analysis
Data arrays were stored as space delimited ASCII files for analysis by
EXCEL software and custom-written macros. Fluorescence intensity (F)
was converted to the percentage fusion of B-av labeled endosomes by
correction for signal background and normalization to the maximal intra-
vesicular B-av signal. Maximal total B-av fluorescence was measured at
the completion of each assay by addition of biotin methyl ester. The
fraction of total B-av that was intravesicular was determined from the
fluorescence enhancement of an acceptor endosome fraction on addition of
biotin dextran (membrane impermeant) to enhance the fluorescence of
external B-av, followed by addition of biotin methyl ester (membrane
permeant) to enhance the fluorescence of all B-av. Generally, 20-50% of
B-av was intravesicular.
RESULTS
Endosome-endosome fusion resolved in
real time
Separate populations of endosomes from BHK-2 1 cells
were labeled by internalization for 10 min at 370C in intact
cells with either B-av ("acceptor" endosomes) or biotiny-
lated-dextran ("donor" endosomes). Previous research dem-
onstrated that B-av is a fluid phase marker of endocytosis
and is delivered to fusogenic early endosomes under these
conditions in vivo (Emans et al., 1995). Postnuclear super-
natant fractions containing the acceptor and donor endo-
somes were prepared as described in Materials and Methods
and mixed in a buffer containing an ATP-regenerating or
-depleting system. Excess unlabeled nonfluorescent avidin
was added to scavenge extravesicular biotin dextran and
thus prevent any fluorescence enhancement of extrave-
sicular B-av. Assay mixtures were placed in the mi-
crofluorimeter at 37°C for continuous measurement of
B-av fluorescence.
Endosome-endosome fusion results in an enhancement
of B-av fluorescence as donor endosomes containing an
excess of biotin dextran fuse with acceptor endosomes
containing B-av. Fig. IA shows the time course of fluores-
cence enhancement of B-av on incubation of the donor and
acceptor fractions at 37°C in the presence of an ATP-
regenerating (+ATP) or -depleting (-ATP) system. In the
presence of an ATP-regenerating system, the "fusion sig-
nal" consisted of a lag phase (10-15 min) in which little rise
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FIGURE 1 Real-time assay of endosome-endosome fusion. (A) Post-
nuclear supernatants were prepared from cells that internalized B-av or
biotin-dextran for 10 min at 37C. Endosome fractions (8 mg total protein/
mL) were mixed in fusion buffer containing an ATP-regenerating system
(+ATP) or an ATP-depleting system (-ATP). Assays were performed at
37°C. Maximum BODIPY fluorescence was obtained by addition of mem-
brane-permeable biotin methyl ester (+biotin methyl ester). (B) Mean +
SE for percentage fusion at 1 h: n = 27 (+ATP), n = 12 (-ATP). (C) A
constant volume of acceptor endosomes was diluted with increasing vol-
umes of donor, supplemented with an ATP-regenerating system (represen-
tative of four sets of experiments). Data are expressed as % fusion as
described in Materials and Methods.
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in fluorescence occurred, followed by a monotonic rise to a
stable level after -45 min. A lag phase has been reported in
comparable classical assays of endosome fusion (Diaz et al.,
1989a). In addition, a small increase in fluorescence (<5%
fusion) was often observed in the first 2 min of the assay
(see below). At the end of the assay, a cell-permeable biotin
derivative (biotin methyl ester) was added to give the max-
imal B-av fluorescence enhancement for calculation of fu-
sion efficiency (see Materials and Methods). The ATP-
dependent fluorescence signal was 15 ± 0.1% (SE, n = 27)
of the latent avidin signal after addition of biotin methyl
ester, compared with 2.2 ± 0.1% (n = 12) in the presence
of the ATP-depleting system (Fig. 1 B).
The fusion signal was sensitive to temperature. Fusion
was undetectable when the assay was carried out at 22°C
and 26°C; at higher temperatures, where fusion could be
detected, the percentage fusion at 1 h relative to that at 37°C
was 58 ± 8% (32°C, n = 3) and 46 ± 7 (42°C, n = 3).
These data are in qualitative agreement with previous tem-
perature-dependence studies (Braell, 1987, 1992; Colombo
et al., 1992a).
In control studies (in the presence of an ATP-regenerat-
ing system), addition of detergent (0.1% Triton X-100) at 0
or 60 min did not produce an enhancement in fluorescence
signal, indicating that sufficient excess unlabeled avidin
was present to block any signal increase from extravesicular
B-av. The fluorescence of BODIPY-fluorescence from a
"blank" assay containing acceptor endosomes alone
changed by <1% over 60 min, indicating absence of pho-
tobleaching under the experimental conditions. It is noted
that, for experiments performed on six parallel samples,
each vial was illuminated for only -7% of the time; fur-
thermore, the large (4-mm-diameter) spot size of the inci-
dent beam produced a relatively low illumination intensity
in the aqueous sample.
The dependence of the fusion signal on the relative pro-
portion of acceptor and donor endosomes was investigated.
Fig. 1 C shows that an increasing proportion of donor
(biotin-containing) endosomes produced a larger fusion sig-
nal with little effect on the lag phase. This result is in
agreement with the prediction that the probability of an
avidin-containing endosome successfully fusing with a bi-
otin-containing endosome should increase with the number
of available biotin-containing endosomes. It is also noted
that the relative proportion of donor and acceptor endo-
somes (at constant total protein) had relatively little influ-
ence on the duration of the lag phase (see below).
Sensitivity of the assay to known modulators of
endosome fusion
There is a considerable body of evidence indicating that
endosome fusion is sensitive to modulators of monomeric
and trimeric GTPase activity (Colombo et al., 1992b; Gor-
vel et al., 1991; Lenhard et al., 1994; Mayorga et al., 1989;
Colombo et al., 1994). Assays were performed as in Fig. 1
A with addition of the nonhydrolyzable GTP analog GTPRyS
just before the assay (Fig. 2A). Fusion was effectively
blocked at 50 ,uM GTPyS, in agreement with previous
observations (Gorvel et al., 1991). Interestingly, the small
increase in fluorescence over the first few minutes was not
blocked by GTPyS. The compound AlF4- activates trimeric
G proteins but does not affect ras-like small GTPases
(Kahn, 1991; Stryer and Bourne, 1986; Gilman, 1987).
Assays were carried out with AlCl3 alone, KF alone, or
AlCl3 and KF in combination to give the final specified
concentrations of AlF4- (Fig. 2 B). AlCl3 and KF had little
effect individually but inhibited fusion when added to-
gether, in agreement with previous cell-free-fusion studies
(Mayorga et al., 1989). The N-ethylmaleimide (NEM) sen-
sitivity of endosome fusion has implicated NEM-sensitive
factor in endosome fusion; effects of NEM can be reversed
by addition of purified NEM-sensitive factor (Diaz et al.,
1989b). To determine whether an NEM-sensitive factor was
required here, we performed experiments with endosomes
pretreated with 1 mM NEM for 30 min at 4°C. NEM
pretreatment completely abolished the fusion signal (Fig. 2
B). Taken together, the ATP and temperature dependencies
of the fusion signal, and its sensitivity to GTPRyS, AIF4-,
FIGURE 2 Sensitivity of endosome-
endosome fusion to known modulators of
fusion, nucleotide analogs, and NEM. Ac-
ceptor and donor fractions were mixed, and
the assays were carried out at 37°C in the
presence of an ATP-regenerating system.
(A) GTPyS was added before the temper-
ature was raised. Plots are representative of
six sets of experiments. (B) Summary
(mean ± SE, n = 3) of endosome fusion
inhibition studies. Where indicated, accep-
tor and donor fractions were separately
pretreated with 1 mM NEM for 30 min at
4°C. Excess NEM was quenched by 2 mM
DTT for 15 min at 40C before mixing
endosome fractions, adding the ATP-re-
generating system, and raising the temper-
ature (n = 6).
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and NEM, support the conclusion that the fluorescence
assay is detecting endosome-endosome fusion.
Endosome-endosome fusion is preceded by a
lag phase
Fig. 1 A showed that the increase in endosome fusion was
preceded by a lag phase of 10-15 min during which little
fusion was detected, similar to previous observations for
cell-free endosome fusion (Diaz et al., 1989a) and intra-
Golgi transport (Balch et al., 1984). The characteristics of
the lag phase were investigated under conditions in which
fusion was reversibly inhibited (low temperature) or would
not be detected (separate incubation of acceptor and donor
membranes at 37°C).
The lag time was significantly reduced by separate pre-
incubation of acceptor and donor fractions at 37°C (in the
presence of an ATP-regenerating system) for a time com-
parable with the lag time (Fig. 3A; the dashed lines indicate
preincubation time period). Preincubation of the donor and
acceptor fractions together at 4°C had little effect on the lag
(Fig. 3 A, 40C coincubation), yet coincubation at 22°C, a
temperature that blocks fusion (see above), markedly re-
duced the lag phase. The lag time was progressively short-
ened with increasing coincubation time at 220C. Also, the
lag phase was nearly eliminated when the assay was per-
formed at higher concentrations of endosomes and cytosol
(13 mg protein/mL; Fig. 3 B). At this higher protein con-
centration, coincubation of endosome fractions at 220C re-
sulted in an increased rate of fusion after the temperature
was increased to 370C (Fig. 3 C).
As explained below, the preincubations and increased
protein concentration could reduce the lag time by permit-
ting one or more of the following rate-limiting steps to
occur: 1) binding of a soluble protein to the endosome
surface (priming), 2) binding of endosomes to form a pre-
fusion intermediate (binding/recognition), and/or 3) cre-
ation of a transport intermediate that accumulates because it
is not consumed by fusion (vesicle budding). It was rea-
soned that the results support possibility 1 in which there is
priming of endosomes, likely corresponding to the rate-
limiting binding of a soluble protein required for endosome
fusion (see Discussion).
Endosome fusion is sensitive to cytosolic
second messengers
The fluorescence assay was next utilized to test whether in
vitro fusion of early endosomes is regulated by activation of
protein kinases involved in signal transduction: protein ki-
nase A, protein kinase C, and Ca2+-calmodulin-dependent
protein kinase. Representative fusion data are shown in Fig.
4, and the results from a series of studies are summarized in
Fig. 5. Addition of the protein kinase A activator cAMP
remarkably reduced the extent of fusion without blocking
the initial early fusion signal (Fig. 4 A). Addition of the
kinase inhibitor H89 had a slight stimulatory effect on
fusion but at concentrations of up to 2.5 ,tM did not reverse
the cAMP effect (data not shown). Activation of protein
kinase C by PMA or inhibition by Go6976 had no signifi-
cant effect on fusion. Inhibition of the Ca2+-calmodulin
kinase with KN-62 did not affect fusion; however, addition
of purified bovine brain calmodulin (single band by SDS-
PAGE, not shown) at concentrations lower than those used
in permeabilized cell assays of exocytosis (Chamberlain et
al., 1995) inhibited fusion (Fig. 4 B).
DISCUSSION
The initial aim of this study was to develop a sensitive
fluorescence assay to monitor cell-free endosome fusion
continuously in real time. The development of a real time
assay of endosome fusion was inspired by the real-time
assay of influenza virus: cell fusion and the subsequent
FIGURE 3 The lag phase is sensitive to prein-
cubation, temperature, and protein concentration.
(A) The control assay was performed as in Fig. 1
A. Acceptor and donor fractions (8 mg protein/
mL) were separately preincubated at 37°C (37°C
separate incubation) or together at 22°C (22°C
coincubation) or 4°C (4°C coincubation). An
ATP-regenerating system was present during the
preincubations. The dashed lines indicate the
time of preincubation. Plots are representative of
four sets of experiments. (B) The lag phase was
abolished by carrying out the fusion assay at a
higher protein concentration (13 mg/mL). (C) At
the higher concentration (13 mg protein/mL), in-
cubation of endosome fractions at 22°C (22°C
coincubation) resulted in an increased initial rate
of fusion. Representative of three sets of experi-
ments.
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FIGURE 4 Endosome fusion is sensitive to cAMP and calmodulin. (A)
Inhibition of endosome fusion by cAMP. Curves shown are representative
of 10 experiments in which cAMP was added just before the assay. (B)
Purified bovine brain calmodulin was added before the assay was supple-
mented with an ATP-regenerating system and the temperature was raised.
Plots are representative of eight sets of experiments.
elegant elucidation of viral fusion mechanisms (Zimmer-
berg et al., 1995; Hoekstra and Klappe, 1993; Puri et al.,
1993). Fusion of early endosomes in BHK cells was chosen
as the model system because of the relative ease of endo-
some loading with fluorescent markers and the substantial
body of experimental data from classical assays on the
factors regulating fusion (Gruenberg and Howell, 1989).
Our assay exploited the discovery that B-av undergoes a
large, rapid, irreversible, and pH-independent fluorescence
enhancement on biotin binding and that this enhancement
could be used to quantify endosome fusion in vivo (Emans
et al., 1995). Endosome fusion could be reproducibly mea-
sured in a relatively crude postnuclear supematant fraction
with high sensitivity from endosomes derived from as few
as 4 X 104 cells.
As mentioned in the Introduction, the fluorescence assay
has several advantages over conventional biochemical as-
says of the intermixing of endosomal contents. The fluores-
cence assay permits continuous quantitative resolution of
vesicle fusion over time in a single experiment, whereas
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FIGURE 5 Summary of effects of cytosolic second messengers and
inhibitory factors on fusion of early endosomes. Data indicate percentage
fusion at 60 min (mean ± SE), with numbers of experiments shown in
parentheses.
conventional assays are limited to single-time-point resolu-
tion per assay. Generally, conventional assays have been
applied to measure the extent of fusion at a predetermined
end point and give no information on the kinetics of fusion
during the experiment; in some studies, limited time reso-
lution of the order of tens of minutes was obtained from
measurements performed at multiple time points (Aniento et
al., 1993; Diaz et al., 1989a). The real-time assay here
provides a complete profile of fusion kinetics in a single
assay, permitting the resolution of rate-limiting processes
(e.g., lag phases) and the determination of the effects of
putative regulatory factors on the rate and extent of endo-
some fusion. We have estimated that the present-day cost of
the classical avidin assay is >12 U.S. dollars per single time
point (estimated from Gruenberg and Gorvel, 1992), com-
pared with a total cost of <1 dollar for a complete time
course with the fluorescence assay.
In addition to the kinetic information about fusion rates,
the assay provides accurate and reproducible information on
the extent of fusion at specific end points (see Fig. 1 A). In
agreement with previous results from research that utilized
biochemical assays, the fluorescence assay indicated that
fusion of early endosomes was sensitive to ATP, tempera-
ture, a nonhydrolyzable guanine nucleotide analog, activa-
tion of trimeric G proteins, and the sulphydryl modifier
N-ethylmaleimide. The fluorescence assay thus displays
qualitatively similar characteristics to established assays of
cell-free endosome fusion, and the findings here are in
agreement with a large body of evidence that implicates a
key role in endosome fusion of monomeric GTPases, trim-
eric G proteins, and NSF (Colombo et al., 1992b; Diaz et al.,
1989b, Gorvel et al., 1991; Lenhard et al., 1994; Colombo
et al., 1994).
There were several important technical considerations
in the design of the microfluorimeter for measurement of
endosome fusion. Microscope optics were chosen to
quantify fluorescence in a small volume of a turbid
endosome suspension. A movable microscope stage was
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constructed to make parallel measurements in multiple
samples over an extended assay period (generally >1 h)
with a time resolution of seconds. 1800 illumination and
detection optics were chosen over epi-illumination based
on initial results showing significant autofluorescence
(compared to a sample signal) from dichroic mirrors. In
addition, because of the small BODIPY fluorescence
enhancement signal, the illumination and detection elec-
tronics were selected for high stability and low drift; it
was found that commercial multiplate fluorescence read-
ers did not have adequate sensitivity or stability to detect
endosome fusion in our assay.
The time course of endosome fusion demonstrated a
distinct lag phase that was dependent on protein concentra-
tion and various incubation conditions (Fig. 3). The lag was
remarkably diminished by preincubation of endosome frac-
tions separately with ATP at 37°C and by coincubation of
endosomes at 22°C, a temperature at which fusion did not
occur. Several rate-limiting processes could account for
these observations; they include 1) binding of a soluble
protein to the endosome membrane (priming), 2) binding of
endosomes to form a prefusion intermediate (binding/rec-
ognition), and 3) creation of a transport intermediate that
accumulates because it is not consumed by fusion (vesicle
budding). It is unlikely than an endosome-endosome inter-
action (binding/recognition) is responsible for the lag be-
cause preincubation of endosomes separately at 37°C abol-
ished the lag. The observations that coincubation at 22°C
diminished the lag but that coincubation at 4°C had no
effect suggest that vesicle budding is not the rate-limiting
process accounting for the lag. Vesicle budding is temper-
ature sensitive in vitro (Tooze and Huttner, 1990), and there
is biochemical evidence that endosomes fuse directly with
endosomes (Emans et al., 1993).
Our working hypothesis is that a "priming" factor must
be recruited to the endosome before fusion and that this
process is inhibited at 4°C but can proceed at 22°C. A
potential candidate for such a priming factor is ARF6, a
member of the ARF-like multigene family defined by the
ability to activate cholera toxin (Moss and Vaughan,
1995). ARFs have been demonstrated to regulate the
priming of endosome membranes before fusion and to
stimulate the rate of fusion in vitro (Lenhard et al., 1992,
1994). Overexpressed ARF6 localizes to endosomes and
to the plasma membrane (D'Souza-Schorey et al., 1995;
Peters et al., 1995) and slows the rate of transferrin
uptake without effect on the secretory pathway
(D'Souza-Schorey et al., 1995). Association of the AP-1
adaptor complex with Golgi membranes is mediated by
ARFI, and a lag phase that precedes binding has been
proposed to represent the time required to recruit ARFI
to the membrane (Traub et al., 1993). The association of
ARF with Golgi has also been demonstrated to be tem-
perature sensitive and blocked at 0°C (Traub et al., 1993).
Further studies are indicated to test the hypothesis that
the lag phase is dependent on ARF6 recruitment.
Cyclic AMP activates a diverse set of cellular re-
sponses generally involving protein phosphorylation by
the protein kinase A pathway. The rate of fluid-phase
endocytosis is slowed by cAMP agonists in a number of
cell types (Zen et al., 1992; Bradbury and Bridges, 1992).
In vitro endosome fusion was found here to be remark-
ably inhibited by addition of cAMP. Further research will
be required to determine whether this inhibition is a
primary interaction of cAMP with the fusion machinery
or a secondary effect on other regulators of endosomal
fusion such as Gs (Colombo et al., 1994). In any case, the
cAMP effect provides evidence that cytosolic second
messengers modulate endosome fusion in vitro and may
provide an explanation for the inhibition of endocytosis
in intact cells by cAMP agonists.
Calmodulin has been demonstrated to be involved in
exocytosis in chromaffin cells (Chamberlain et al., 1995)
and endocytosis in yeast (Mu et al., 1995). Calmodulin
kinase antagonists perturb apical and basolateral endocytic
pathways in polarized cells, suggesting a role in maintaining
separate endocytic pathways (Hunziker, 1994; Apodaca et
al., 1994). The addition of purified bovine brain calmodulin
significantly inhibited endosome fusion (Fig. 5). A calmod-
ulin-binding protein present in early endosomes was cloned
recently (EEA-1; Mu et al., 1995) and shares homology
with yeast proteins involved in endocytosis [FAB1] and
vacuolar protein sorting [VPS 11, VPS l8p, VAC 1] (Robin-
son et al., 1991; Weisman and Wickner, 1992). EEA-1 may
thus be the calmodulin target protein responsible for the
inhibition of fusion found here.
The fluorescence-based cell-free assay established in this
study should have a number of applications in the identifi-
cation and mechanistic analysis of factors affecting the
fusion of various intracellular vesicles. The possibility of
comparing cell-free and intact-cell data directly, utilizing
essentially the same assay conditions, should be useful in
testing in vivo the implications of observations made in
cell-free assays.
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